Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01773967 · ClinicalTrials.gov registry record · Phase 2
Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis
A Phase 2 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 971
- Enrollment target
NCT01773967 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 971 participants.
The verdict
NCT01773967, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 971 participants
- Enrollment target
Study Summary
The investigators will study the efficacy and side effect profile of LGG, a probiotic, in pediatric patients with acute gastroenteritis.
Interventions
- DRUG LGG
- DRUG micro-crystalline cellulose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 971 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01773967
The ClinicalTrials.gov registry entry for NCT01773967 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 971 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LGG is the first listed.
NCT01773967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01773967 about?
NCT01773967 is a clinical study titled "Impact of Emergency Department Probiotic (LGG) Treatment of Pediatric Gastroenteritis". The investigators will study the efficacy and side effect profile of LGG, a probiotic, in pediatric patients with acute gastroenteritis.
What is the current status of trial NCT01773967?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 971 participants. The study started on 2014-07. Estimated completion is 2018-08.
What interventions are being tested in trial NCT01773967?
The interventions under investigation include: LGG (DRUG), micro-crystalline cellulose (DRUG).
Who is sponsoring clinical trial NCT01773967?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.